Baxter follows the rigorous US Food and Drug Administration (FDA) and European Medicines Agency (EMEA) policies and criteria for plasma donation centers. Baxter also voluntarily complies with the Plasma Protein Therapeutics Association (PPTA), and PPTA’s International Quality Plasma Program (IQPP) standards to safeguard the collection of plasma used for plasma-derived therapies.